Veracyte | VCYT - Loan Capital


Veracyte reported $0 in Loan Capital for its fiscal quarter ending in March of 2025.





Loan Capital Change Date
Agenus USD 169.66M 146.06M Dec/2025
Agilent USD 3.05B 0 Dec/2025
Anika Therapeutics USD 25M 25M Sep/2020
Arrowhead Research USD 538.1M 323.22M Dec/2025
Bruker USD 1.85B 131.7M Dec/2025
Exact Sciences USD 2.33B 9.34M Sep/2025
Heron Therapeutics USD 140.64M 975K Dec/2025
Illumina USD 1.49B 496M Dec/2025
Intrexon USD 0 198.67M Jun/2024
Karyopharm Therapeutics USD -0.93 0.67 Dec/2024
Laboratory Of America USD 5.15B 800K Dec/2025
Ligand Pharmaceuticals USD 445.49M 445.44M Sep/2025
Myriad Genetics USD 119.9M 400K Dec/2025
Rigel Pharmaceuticals USD 0 0 Sep/2024
Roche Holding CHF 27.43B 966M Dec/2025
Sangamo BioSciences USD 0 0 Jun/2022
Siemens EUR 42.84B 2.01B Dec/2025
Sonic Healthcare AUD 4.19B 333.39M Dec/2024
Thermo Fisher Scientific USD 35.85B 4B Dec/2025
Veracyte USD 0 0 Mar/2025
Waters USD 1.41B 460.24M Dec/2025